AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05076123 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Modified Constraint Induced Therapy and Threshold Electrical Stimulation
Description: M-CIMT emphasizes massed practice with the affected upper limb with restraining unaffected limb by a mitt. Threshold electrical stimulation is based on low-intensity (\<100 Hz) and long-duration current and is applied with superficial electrodes.
Study NCT05568290 — intervention group
Intervention type: OTHER
Intervention: Saliva
Description: individuals' saliva samples will be collected and transferred to eppendorf tubes.~Until biochemical analysis is carried out will be stored in -80ºC.
Study NCT05568290 — intervention group
Intervention type: OTHER
Intervention: gingival crevicular fluid
Description: GCF samples of individuals will be collected by paper strips and transferred to eppendorf tubes.Until biochemical analysis is carried out will be stored in -80ºC.
Study NCT06122181 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HS-10384 tablets
Description: Multiple dosing of HS-10384 orally in a fasting state
Study NCT06122181 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: HS-10384-matched placebo tablets
Description: Multiple dosing of HS-10384-matched placebo orally in a fasting state
Study NCT06115980 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: lead extraction (Xtrac O.S. system)
Description: This is an open label, non-randomized, feasibility, prospective, interventional clinical trial of lead extraction. The Xtrac O.S. system is intended for transvenous removal of pacing or defibrillator leads, having an inner lumen, through a superior approach.~The decision upon lead extraction will be based upon the applicable Heart Rhythm Society guidelines or European Heart Rhythm Association (EHRA).~Each enrolled patient will undergo a pre procedural evaluation to enable planning of the extraction procedure. The evaluation includes an assessment of the CIED components to be removed, dwell time, anatomic course on radiography and patient characteristics that may require management prior to extraction.~A multidisciplinary team evaluation involving cardiac surgery, electrophysiologist, and cardiac anesthesiology should allow for a rapid and successful response to major complications
Study NCT04870203 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: baricitinib treatment
Description: 4 mg daily during 12 months
Study NCT04870203 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: baricitinib treatment
Description: 4 mg daily during 12 months
Study NCT04870203 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: adalimumab
Description: 40 mg every 2 weeks during 6 monts
Study NCT04870203 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 40 mg every 2 weeks during 6 months
Study NCT06209606 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ruxolitinib Oral Tablet [Jakafi]
Description: Ruxolitinib will be administered on days 1-28 of the treatment cycle.
Study NCT06209606 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide
Description: Lenalidomide will be administered on Days 1-21 of the treatment cycle.
Study NCT06209606 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methylprednisolone
Description: Methyl-prednisolone will be administered on Days 1-28 of the treatment cycle.
Study NCT05178927 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HoloLens v2
Description: The HoloLens v2 will be used to access the participant's hologram \& set the participant up for treatment. Standard of care methods will be utilized to confirm treatment set-up.
Study NCT05178927 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: HoloLens v2
Description: The HoloLens v2 will be used to access the participant's hologram \& set the participant up for treatment. Standard of care methods will be utilized to confirm treatment set-up.
Study NCT06563206 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Exergame
Description: Hand Training assisted with Virtual-Reality
Study NCT06563206 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Robotic
Description: Hand Training assisted with Robotic Syrebo
Study NCT06563206 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional
Description: Hand Training with Physical Therapist
Study NCT05168735 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Intravenous Ketamine
Description: Single infusion of intravenous racemic ketamine (0.5mg/kg over 40min)
Study NCT05168735 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intravenous Ketamine
Description: Single infusion of intravenous racemic ketamine (0.5mg/kg over 40min)
Study NCT05168735 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief Mindfulness Exercises
Description: 30min guided training in mindfulness meditation immediately prior to infusion
Study NCT05168735 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Academic Exercises
Description: 30min of mental math and other academic cognitive puzzles completed silently/mentally
Study NCT05212363 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Lower extremity compression garments
Description: Compression garments are used to exert external pressure on the lower extremities to reduce vascular wall tension and prevent gravity form pooling blood in the lower extremities which will improve venous return and lymphatic output. Following the resting measurements, subjects will be instructed to wear the garments and moved to the seated gaming position for 2 hours.
Study NCT05212363 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Active break
Description: An active break is currently considered gold standard for increasing blood flow after prolonged sitting. The 6-minute walk will be conducted indoors next to the esport lab in the Wisser library at NYIT, Old Westbury. Participants will be asked to walk for 6 minutes on a flat surface back and forth following one hour of game play.
Study NCT04681534 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AlphaDBS System
Description: AlphaDBS can be programmed with two different types of stimulation: conventional DBS and adaptive DBS, that automatically adjusts the energy delivered to patient using a biosignal, local field potential (LFP), in a close loop configuration.
Study NCT04681534 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: AlphaDBS System
Description: AlphaDBS can be programmed with two different types of stimulation: conventional DBS and adaptive DBS, that automatically adjusts the energy delivered to patient using a biosignal, local field potential (LFP), in a close loop configuration.
Study NCT05043376 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Standard of care
Description: Standard COVID-19 care as per the hospital guidelines
Study NCT05043376 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standard of care
Description: Standard COVID-19 care as per the hospital guidelines
Study NCT05043376 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: BLIS K12
Description: Daily 2 oral BLIS K12 tablets for up to 14 days.
Study NCT06382883 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Individually tailored lifestyle and physical activity intervention
Description: Focus of the SEMC-protocol is on increasing PA gradually towards the national recommendations. Emphasis of counseling is on incidental exercise, endurance, and strength training. Techniques of motivational interviewing are utilized.~Baseline; MD+PT counseling, medical clearance, mapping lifestyle \& life situation, goal setting, measurements, questionnaires, feedback. weeks 1-6: guided group resistance training 1hr, 1x/week. 5-10-minute warm-up, 9 exercises with weight stack equipment on large muscle groups. 2-3 sets, 12-15 repetitions. Modified individually, e.g. according to musculoskeletal problems. Emphasis on learning the basics and safety aspects. After 6 weeks unsupervised training. 3-month: MD counseling and questionnaires. 6-month: MD+PT counseling, assessing safety of PA, measurements, questionnaires, feedback. 12-month: MD+PT counseling (feedback, ensuring continuity of lifestyle changes; redirecting to municipality/NGO activities), measurements, questionnaires, feedback
Study NCT06382883 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Individually tailored lifestyle and physical activity intervention combined with enhanced behavioral support -intervention (EBS)
Description: In addition to the SEMC-protocol, the participants will be contacted 3 times during the first 3 months (live / online as preferred). Themes:~Session 1: Motivation and illness perceptions. Exploring CPAP use, PA, and SB. Session 2: Self-regulation (feedback, goal setting, self-monitoring, action planning, problem solving), activating social support, prompts/cues, and preparatory behaviors. (Included BCTs from Michie et al 2013 taxonomy: 3.2, 12.2, 8.3,) Session 3: Assessing progress and agenda setting, self-regulation, maintenance of PA.~Measurements and questionnaires as with SEMC-protocol.
Study NCT04887480 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Abthera™ Open Abdomen Negative Pressure Therapy Device System
Description: Suction set at -125mmHg
Study NCT04887480 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dianeal PD-2 with 2.5% Dextrose
Description: 800mL to 1000mL of Dianeal PD-2 into Abthera™ and dwell for 1 hour.
Study NCT05659381 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Cisplatin 100mg/m2 IP over 90 minutes at 42 degrees Celcius
Study NCT05659381 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: No treatment
Description: No treatment with Cisplatin
Study NCT06067243 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: T2 mapping 3T MRI + hip arthroscopy
Description: 1. 3T MRI~2. hip arthroscopy
Study NCT04804605 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ARQ-151 Cream 0.15% or ARQ-151 Cream 0.05%
Description: ARQ-151 Cream
Study NCT05654922 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ARINA-1
Description: ARINA-1 (88 mg/mL ascorbic acid, ASC; 150 mg/mL reduced glutathione, GSH)
Study NCT05654922 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Standard of care only
Description: Standard 3-therapy immunosuppression regimen and azithromycin
Study NCT04081298 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Health Education
Description: Attend nutrition and PA classes, and cooking sessions
Study NCT04081298 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical Activity
Description: Participate in physical activities
Study NCT04081298 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Health Promotion and Education: Text Messages
Description: Receive motivational text messages
Study NCT04081298 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Health Promotion and Education: Web Site
Description: Given access to nutrition website
Study NCT04081298 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study NCT04081298 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT06355908 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: IL13Rα2 CAR-T
Description: The IL13Rα2 CAR-T cells will be administered via intraventricular infusion every 2 weekly via an Ommaya reservoir.
Study NCT04888481 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 68Ga-HA-DOTATATE
Description: Tracer injection
Study NCT04977947 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Healthy Eating for My Infant
Description: The intervention targets problem solving to overcome barriers, behavioral rehearsal and practice of healthy behaviors, promoting readiness to change, goal setting, self-monitoring, and behavioral tracking. Two standard treatment modules will be provided to each family by a study interventionist focusing on infant nutritional requirements, responsive feeding, and mealtime behaviors. Two additional treatment modules will be selected to address the unique needs articulated by each family (e.g., food insecurity, eating healthy on a limited income, emotional eating, engaging other caregivers, maternal mental health). Modules will consider the influence of maternal trauma history and mental health on feeding and eating behavior. The intervention also includes two peer counselor-led sessions during which families can discuss implementation of recommendations and barriers to change with a member of their community who can problem solve and support change.
Study NCT05805865 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Toothpaste Tablet
Description: Colgate Anywhere Toothpaste Tablets
Study NCT05805865 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Toothpaste
Description: Colgate Cavity Protection
Study NCT05324098 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: STAND-T platform
Description: Internet-based intervention comprised of evidence-based, patient materials and resources
Study NCT05324098 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Survey Administration
Description: Satisfaction and follow-up surveys will be administered to participants
Study NCT05324098 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Text Messages
Description: Participants will receive periodic text messages
Study NCT05244798 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sintilimab
Description: Sintilimab: D1 administration) for 2 cycles. Every 3 weeks was a dosing cycle (Q3W)
Study NCT05244798 — intervention group
Intervention type: RADIATION
Group type: OTHER
Intervention: radiotherapy
Description: Radiotherapy: According to IMRT treatment plan, the total dose was 41.4Gy, divided into 23 times, 5 days a week.
Study NCT05244798 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: radiotherapy
Description: Radiotherapy: According to IMRT treatment plan, the total dose was 41.4Gy, divided into 23 times, 5 days a week.
Study NCT05244798 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Chemotherapy
Description: Neoadjuvant chemotherapy with TP regimen: albumin-paclitaxel + carboplatin, D1 administration) for 2 cycles. Every 3 weeks was a dosing cycle (Q3W).
Study NCT05244798 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Description: Neoadjuvant chemotherapy with TP regimen: albumin-paclitaxel + carboplatin, D1 administration) for 2 cycles. Every 3 weeks was a dosing cycle (Q3W).
Study NCT05265754 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: sujok therapy
Description: sujok therapy
Study NCT05404659 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Oscillatory Mobilization
Description: conventional physical therapy treatment, postural correction and maitland's oscillatory mobilizitions.
Study NCT05404659 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mckenzie Retraction Exercises
Description: conventional physical therapy treatment, postural correction and Mckenzie retraction exercises.
Study NCT01239017 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: REGN475
Study NCT06413641 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Follow up at GP
Description: As described before
Study NCT01239017 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT04455139 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Topotecan
Description: intravitreal or intra-arterial administration of topotecan
Study NCT04455139 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Melphalan
Description: intravitreal or intra-arterial administration of topotecan
Study NCT04455139 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Melphalan
Description: intravitreal or intra-arterial administration of topotecan
Study NCT03522545 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Allogeneic Bone Marrow Derived Multipotent Mesenchymal Stromal Cells (MSCs)
Description: Allogeneic Bone Marrow Derived Multipotent Mesenchymal Stromal Cells (MSCs) isolated from hematogenous bone marrow
Study NCT03522545 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo for Allogeneic Bone Marrow Derived Multipotent Mesenchymal Stromal Cells (MSCs)
Study NCT05474820 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Samples collection and ELISA analyses
Description: The serum and unstimulated saliva samples were taken from all patients between 8:00 and 10:00 in the morning. Saliva samples were centrifuged at 10,000 rpm (10 min) whereas venous blood samples were centrifuged at 4000 rpm for 10 min.~For the analysis of irisin and IL-6 specific ELISA Kits (Elabscience, Houston, Texas, USA) were used to determine the molecules in both serum and saliva samples in accordance with the manufacturer's instructions. All samples were run in duplicate, and values have been averaged.
Study NCT05474820 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Evaluating periodontal paramètres
Description: The clinical periodontal parameters (plaque index (PI), probing pocket depth (PD), gingival recession (GR), clinical attachment loss (CAL), and bleeding on probing (BOP)) were recorded on periodontal charts in each patient
Study NCT05098990 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Jinfukang oral liquid
Description: Jinfukang koufuye is a Chinese herbal prescription, which is used in treatment for patients with NSCLC in clinical practice. It has been proved to be capable of preventing the occurrence of metastasis, stabilizing tumor lesions, improving the response rates when combined with chemotherapy, and prolonging the survival period of lung cancer patients.
Study NCT05098990 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Platinum-based doublet chemotherapy
Description: Platinum-based doublet chemotherapy as first line therapy has been shown to be efficacious against non-small cell lung cancer.
Study NCT06494163 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: The MICT and HIIT intervention groups will complete supervised virtual exercise sessions for 12 weeks using Zoom care or Microsoft Teams as a backup resource. The appointments will be scheduled and conducted 2 days per week. Initially, exercise intensity will be determined from participants' peak HR achieved during a baseline CPET.
Study NCT06367179 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual reality and AI use
Description: The experimental group will receive interventions of virtual reality and artificial intelligence wound detecting system.
Study NCT06367179 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Health education leaflet
Description: The control group maintained the traditional pressure injury health education with oral introduction and health education leaflet.
Study NCT05787223 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Baseline Treatment
Description: Control Group that will be provided with be given baseline treatment of static balance training (static exercise like standing on balance board, bounce on one foot, heel rises/toe rises, standing on one foot, jumping on trampoline)
Study NCT05787223 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Baseline Treatment
Description: Control Group that will be provided with be given baseline treatment of static balance training (static exercise like standing on balance board, bounce on one foot, heel rises/toe rises, standing on one foot, jumping on trampoline)
Study NCT05787223 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dynamic Training
Description: Experimental Group that will be provided with base line treatment along with dynamic balance training (cross, side \&tandem walking, step up and down, jumping \&hopping on floor). Exercises Will be given the 40 minutes with 2 sessions per week over the period of 08 weeks
Study NCT04664309 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study NCT05309005 — intervention group
Intervention type: BEHAVIORAL
Intervention: VR TASIT
Description: Consists of a Norwegian adaptation of the 59 videos of social scenes that constitute the A Form in the original TASIT. The stimulus material in the Virtual Reality version is perceived through a head mounted display. This allows the test person to watch the scenes in three dimensions and a 360 degree angle, increasing the sense of social presence.
Study NCT05309005 — intervention group
Intervention type: BEHAVIORAL
Intervention: DT TASIT
Description: Consists of a Norwegian adaptation of the 59 videos of social scenes that constitute the A Form in the original TASIT, with identical content as the VR TASIT. The stimulus material in the desktop version is perceived on a two dimensional desktop computer screen.
Study NCT05793944 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: SmartMom text messaging
Description: SmartMom is a mobile health program delivered via text messaging that guides participants through each week of pregnancy. Participants receive three messages per week with links to content focused on improving knowledge, providing information about prenatal assessments and screening, and encouraging the adoption of behaviours to support healthy pregnancy and physiologic birth. Messages are consistent with current professional guidelines and peer reviewed prenatal education curricula. SmartMom provides optional supplemental streams for individuals who wish to have additional messages addressing topics such as reducing use of tobacco, alcohol or illicit drugs, depression, obesity, and maternal age over 35.